Literature DB >> 31544991

LINC00365 promotes colorectal cancer cell progression through the Wnt/β-catenin signaling pathway.

Yiping Zhu1,2, Yinzhu Bian1,3, Qun Zhang4, Jing Hu4, Li Li4, Mi Yang4, Hanqing Qian4, Lixia Yu4, Baorui Liu1,4, Xiaoping Qian1,4.   

Abstract

In the past decade, substantial evidence established that long noncoding RNAs are serious about mediating the evolution of malignancies. In previous studies, LINC00365, which has not been reported in colorectal cancer (CRC), was selected using the bioinformatics analysis in GSE109454 and GSE41655 data sets. However, the function and mechanism of LINC00365 are still obscure. In our study, LINC00365 was found upregulated in CRC specimens and intimately connected with the prognosis of patients with CRC. In addition, LINC00365 overexpression enhances the cell abilities of proliferation, migration, and invasion in vitro. Meanwhile, mechanistic studies showed that LINC00365 might involve in CRC cell progression by mediating the Wnt/β-catenin pathway. Furthermore, LINC00365 upregulation increased CDK1 protein expression. In conclusion, this study suggests that LINC00365 acts as a vital part in facilitating CRC progression and might play as a therapeutic target for patients with CRC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  LINC00365; Wnt/β-catenin signaling; cancer progression; colorectal cancer

Mesh:

Substances:

Year:  2019        PMID: 31544991     DOI: 10.1002/jcb.29359

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Differentially Expressed mRNAs and Their Long Noncoding RNA Regulatory Network with Helicobacter pylori-Associated Diseases including Atrophic Gastritis and Gastric Cancer.

Authors:  Songyi Liu; Honghao Yin; Shuwen Zheng; Aining Chu; Yizhi Li; Chengzhong Xing; Yuan Yuan; Yuehua Gong
Journal:  Biomed Res Int       Date:  2020-11-17       Impact factor: 3.411

2.  miR-378a-5p inhibits the proliferation of colorectal cancer cells by downregulating CDK1.

Authors:  Kai Li; Jieling Zhang; Mingkang Zhang; Yaohua Wu; Xinyu Lu; Yiping Zhu
Journal:  World J Surg Oncol       Date:  2021-02-19       Impact factor: 2.754

3.  Integrative analysis of the gastric cancer long non-coding RNA-associated competing endogenous RNA network.

Authors:  Yuyou Jiang; Xianqin Zhang; Li Rong; Yi Hou; Jing Song; Wanfeng Zhang; Min He; Yan Xie; Yue Li; Fangzhou Song
Journal:  Oncol Lett       Date:  2021-04-08       Impact factor: 2.967

4.  Comprehensive Analysis of lncRNAs Related to the Prognosis of Esophageal Cancer Based on ceRNA Network and Cox Regression Model.

Authors:  Chao Li; Wu Yao; Congcong Zhao; Guo Yang; Jingjing Wei; Yuanmeng Qi; Ruoxuan Huang; Qiuyan Zhao; Changfu Hao
Journal:  Biomed Res Int       Date:  2020-12-10       Impact factor: 3.411

5.  Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review).

Authors:  Yong Ji; Jian Lv; Di Sun; Yufeng Huang
Journal:  Int J Mol Med       Date:  2021-10-29       Impact factor: 4.101

Review 6.  Wnt signaling in colorectal cancer: pathogenic role and therapeutic target.

Authors:  Hui Zhao; Tianqi Ming; Shun Tang; Shan Ren; Han Yang; Maolun Liu; Qiu Tao; Haibo Xu
Journal:  Mol Cancer       Date:  2022-07-14       Impact factor: 41.444

7.  Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker.

Authors:  Yaqi Yang; Qin Liu; Xiyuan Guo; Qing Yuan; Siji Nian; Pengyuan Kang; Zixi Xu; Lin Li; Yingchun Ye
Journal:  J Oncol       Date:  2022-08-31       Impact factor: 4.501

8.  The circular RNA circ-GRB10 participates in the molecular circuitry inhibiting human intervertebral disc degeneration.

Authors:  Wei Guo; Kun Mu; Bin Zhang; Chao Sun; Ling Zhao; Hao-Ran Li; Zhan-Yin Dong; Qing Cui
Journal:  Cell Death Dis       Date:  2020-08-13       Impact factor: 8.469

9.  Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer.

Authors:  Yiping Zhu; Kai Li; Jieling Zhang; Lu Wang; Lili Sheng; Liang Yan
Journal:  Cancer Manag Res       Date:  2020-11-04       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.